AtriCure (ATRC) Reports In-Line Q3 EPS; Guides FY15 Revenue Above Consensus
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $58.83 --0%
EPS Growth %: -300.0%
Financial Fact:
Cost of revenue: 10.87M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -300.0%
Financial Fact:
Cost of revenue: 10.87M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q3 EPS of ($0.22), in-line with the analyst estimate of ($0.22). Revenue for the quarter came in at $31.4 million versus the consensus estimate of $31.38 million.
AtriCure sees FY2015 revenue of $129.5-130.5 million, versus the consensus of $128.6 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- Cintas Corp. (CTAS) Tops Q1 EPS by 1c, Offers Guidance
- Worthington Industries (WOR) Tops Q1 EPS by 7c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
